Yes, an HSA can cover GLP-1 medications for weight loss, but only when a physician has diagnosed you with a specific medical condition the drug is treating. If the prescription is for cosmetic weight loss or general wellness, the expense is not qualified, and using HSA funds for it triggers income tax plus a 20% penalty if you are under 65. The line between treating a diagnosed disease and losing weight for appearance is what decides every case.
The IRS Rule That Decides It
The IRS defines qualified medical expenses as those primarily for “the diagnosis, cure, mitigation, treatment, or prevention of disease.” Expenses “beneficial to general health” do not qualify. That language, from IRS Publication 502, controls what you can and cannot pay for with pre-tax HSA dollars.1IRS. Publication 502, Medical and Dental Expenses
For weight-loss expenses specifically, the IRS states that amounts paid to lose weight are qualified only if the weight loss is “a treatment for a specific disease diagnosed by a physician (such as obesity, hypertension, or heart disease).” Weight-loss costs paid “for the improvement of appearance, general health, or sense of well-being” are explicitly excluded.2IRS. Frequently Asked Questions About Medical Expenses Related to Nutrition, Wellness, and General Health
The drug itself is not inherently qualified or disqualified. A Wegovy or Zepbound prescription is HSA-eligible when it treats a diagnosed condition, and it is not eligible when it does not. FDA approval status matters less here than the diagnosis: a doctor can prescribe Ozempic off-label for obesity, and the HSA expense still qualifies, because the IRS rule turns on treating a diagnosed disease rather than matching an FDA label.
Conditions That Make a GLP-1 Prescription Qualify
The IRS recognizes obesity as a specific disease, and a physician’s obesity diagnosis is the most common pathway to HSA eligibility for these drugs. Other diagnosed conditions can also establish medical necessity:
- Obesity or morbid obesity, typically a BMI of 30 or higher.
- Type 2 diabetes, the FDA-approved indication for Ozempic and Mounjaro.
- Hypertension linked to excess weight.
- Heart disease, including cardiovascular risk reduction.
- Other weight-related conditions such as sleep apnea, PCOS, metabolic syndrome, prediabetes, arthritis, acid reflux, back pain, and non-alcoholic fatty liver disease, when a physician prescribes weight loss as treatment.3GoodRx. Are Weight Loss Items an HSA-Eligible Expense
In every case, the qualifying element is a documented physician diagnosis. Wegovy is FDA-approved for weight management at a BMI of 30 or higher, or 27 or higher with a weight-related condition, along with heart disease prevention. Zepbound is approved under the same BMI criteria. Ozempic is approved for type 2 diabetes and cardiovascular risk reduction in diabetic patients but is often prescribed off-label for weight loss. Mounjaro is approved for type 2 diabetes only.4WebMD. Mounjaro, Ozempic, Wegovy, Zepbound Differences
Documentation You Need to Keep
Most HSA administrators require or strongly recommend a Letter of Medical Necessity before approving reimbursement for a GLP-1 weight-loss prescription. Even if yours does not ask upfront, the IRS can audit HSA distributions, and you need documentation to prove the expense qualified.
A Letter of Medical Necessity should include the patient’s name and medical history, the specific diagnosis, the recommended treatment and the reason it is medically necessary, the expected duration, and the provider’s signature and contact information.5GoodRx. Letter of Medical Necessity for HSA and FSA It must come from a treating provider such as a physician or nurse practitioner. If no duration is specified, the letter is generally considered valid for one year.
Also keep the prescription itself, showing medication name, dosage, provider information, and medical indication, along with itemized pharmacy receipts showing the date and amount paid. These are your proof if an administrator or the IRS questions the distribution.
What GLP-1s Cost and How HSA Funds Actually Help
Without insurance, GLP-1 medications typically run between $900 and $1,200 per month at retail pharmacy prices. Manufacturer programs have brought that down for many patients.
Novo Nordisk offers Wegovy through its NovoCare Pharmacy at self-pay rates starting at $149 per month for certain doses, with other doses priced at $199 to $399 depending on strength.6Novo Nordisk. Wegovy Savings Offer Commercially insured patients using a Wegovy savings card can see monthly copays as low as $25.7Novo Nordisk. Wegovy Patient Savings Eli Lilly offers Zepbound through LillyDirect at $299 to $499 per month depending on dose, and LillyDirect orders can be paid directly with an HSA or FSA debit card.8Find Honest Care. Zepbound Cost Through LillyDirect
One important restriction on the Lilly savings card: its terms prohibit seeking HSA or FSA reimbursement for any amount the savings card covers. You can pay with HSA funds, or you can use the savings card, but you cannot claim the discount and then also seek HSA reimbursement for the same dollars.9Eli Lilly. Zepbound Full Terms and Conditions
The pre-tax benefit stands on its own. Someone in the 24% federal bracket paying $300 per month saves roughly $70 to $100 monthly in combined federal and state taxes by using HSA funds instead of after-tax income.
Compounded GLP-1s Are a Gray Area
Compounded semaglutide and tirzepatide have been available through telehealth platforms and compounding pharmacies at lower prices, sometimes starting around $149 per month. These are not FDA-approved products and are not generic equivalents.
The IRS rule does not distinguish between brand-name and compounded prescriptions. If a compounded medication is prescribed by a licensed provider to treat a diagnosed condition, it should meet the definition of a qualified medical expense. In practice, some administrators flag or deny these claims, and HSA retailers note that “HSA/FSA eligibility may vary by plan” for compounded products.10HSA Store. GLP-1s Check with your administrator before spending.
Availability is also narrowing. The FDA declared the semaglutide shortage resolved in February 2025, removing the legal basis most compounders relied on.11FDA. FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize12The Hill. FDA Ozempic Wegovy Drug Shortage List Ruling13FDA. FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide From 503B Bulks List
If Your HSA Claim Is Denied
Administrators sometimes deny reimbursement for GLP-1 prescriptions, especially when documentation is thin or when the drug was prescribed off-label. Start with the specific reason for the denial. Common causes are missing or insufficient documentation, a diagnosis the administrator does not treat as qualifying, or questions about the pharmacy source.
You can typically appeal by submitting additional evidence, including an updated Letter of Medical Necessity that clearly states the diagnosis, the clinical rationale, and why the treatment is medical rather than cosmetic. Include the prescription and itemized receipts. Appeals must be filed within the timeframe the administrator specifies, so act on a denial promptly.
One practical option to discuss with your physician: if a GLP-1 was prescribed for weight management and denied, but you also have a qualifying condition like type 2 diabetes or cardiovascular disease, the same medication may be prescribed under that alternative diagnosis. Claims tied to diabetes treatment tend to face less scrutiny than claims tied to weight management alone.14Everyday Health. I Lost Access to My GLP-1 Weight Loss Drug, What Now
What Happens If You Use HSA Funds for a Non-Qualified GLP-1
Using HSA funds for a non-qualified expense is not just an administrative issue. The withdrawn amount is taxed as income, and if you are under 65, the IRS adds a 20% excise tax on top. On a $1,000 monthly prescription, the combined penalty can exceed $300 per withdrawal.15GoodRx. Are Weight Loss Items an HSA-Eligible Expense If you are unsure whether your situation qualifies, get the Letter of Medical Necessity from your doctor and confirm with your HSA administrator before spending the funds.